Cell Culture Technology– category –
-
eXoZymes Selected for DOE’s Genesis Mission to Revolutionize Cell-Free Biomanufacturing with AI-Powered Digital Twins
Stock Titan USA Overview eXoZymes has been chosen for the US Department of Energy's Genesis Mission to advance AI-powered digital twins for cell-free biomanufacturing. The company will leverage hybrid models integrating enzyme kinetics, ... -
Cultivated Meat Regulation Matures Globally: US Federal Approvals, ANZ Standards, and UK Guidance Set New Benchmarks
Dr. Mercola International Overview The global regulatory environment for cultivated meat is rapidly advancing, with five products completing federal review in the US, alongside new cell-cultivated food standards in Australia/New Zealand ... -
Sartorius Drives Bioprocessing Evolution: New Ambr 250 HT and Pionic Modules Fast-Track Cell Therapies and Continuous Manufacturing
Sartorius boerse.de Investing.com Germany Overview Sartorius reported strong H1 2026 growth, largely fueled by new innovations in its Bioprocess Solutions Division. Key launches include the Ambr 250 HT Cell Therapies Vessel, designed for... -
AGC Biologics Secures Landmark Multi-Hundred-Million-Dollar Deal for Yokohama Facility, Cementing Japan’s Biologics Manufacturing Leadership
AGC Biologics Japan Overview AGC Biologics has secured a multi-year, multi-hundred-million-dollar commercial manufacturing agreement for its new Yokohama facility, slated to open in 2027. This landmark deal dedicates approximately half o... -
Experimental Study Illuminates Critical Process Parameters for Human NK Cell Manufacturing, Successfully Builds Statistical Model for Viable Cell Yield Prediction via Design of Experiments
Frontiers International Overview A groundbreaking experimental study, employing Design of Experiments (DoE), has precisely elucidated the impact of Critical Process Parameters (CPPs) on Critical Quality Attributes (CQAs) during human NK ... -
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not... -
Perfusion Bioreactor Market Surges Driven by Continuous Biomanufacturing and Intensified Bioprocessing; Thermo Fisher’s DynaDrive Platform Leads
Constancy Researchers USA Overview The perfusion bioreactor market is experiencing rapid growth, primarily fueled by the adoption of continuous biomanufacturing and intensified bioprocessing strategies. Thermo Fisher Scientific's HyPerfo... -
Thermo Fisher Unveils DynaDrive 5L Single-Use Bioreactor, Enabling Seamless 1L to 5,000L Scale-Up for Biologics Manufacturing
Constancy Researchers USA Overview Thermo Fisher Scientific has launched its DynaDrive 5L single-use bioreactor, designed to enhance workflow efficiency in biopharmaceutical manufacturing. This new system facilitates seamless culture sca... -
Cell Culture Technology Weekly Report July 26, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report July 26, 2026 (PDF) — Download Weekly Report July 26, 2026 (PDF) — DownloadDownload 🎙 Podcast July 26, 2026 (... -
Breakthroughs in iPSC and 3D Organoids Drive Stem Cell Therapies Towards Clinical Reality and Scalable Manufacturing
Academic/Industry Publication Unknown Overview Stem cell therapies are transitioning rapidly from promise to clinical reality, driven by recent advances in iPSC generation and differentiation. Innovative transcription factor mixes now en...
